Alaunos Therapeutics | ZIOP - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Baxter International USD 2.01B 231M 2025-12
Biogen USD 1.85B 234M 2025-09
Bioline Rx USD 699K 418K 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Celltrion KRW 1.51T 128.69B 2025-09
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Cspc Pharmaceutical CNY 8.85B 769.12M 2025-06
Curis USD 2.55M 400K 2024-06
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
J&J USD 17.61B 235M 2025-09
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Merck USD 12.12B 596M 2025-09
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Organigram Holdings CAD 49.94M 14.92M 2025-12
Ovoca Bio EUR 447K 113K 2022-06
Pfizer USD 18.12B 2.02B 2025-09
Pharma Mar EUR 60.6M 18.83M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sartorius EUR 344.7M 48.5M 2025-09
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
TG Therapeutics USD 265.38M 33.86M 2025-09
Tilray USD 109.07M 2M 2025-09
Verastem USD 200K 10.72M 2024-09
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.12B 222.78M 2025-09